Between 2005 to 2015, the pharma sector was one of the best performing sectors with stocks creating big wealth for the shareholders. Then c...

A high-level government committee, which submitted its report to the Department of Pharmaceuticals (DoP) last week, reviewed 54 drugs and s...

The move comes as traders raise prices of some bulk drugs for pharma firms amid shutdown in China.

Promoters held 46.70 per cent stake in the company as of June 2017.

Here is a list of top stocks that are likely to be in focus in today's trading session.

The company has received final approval from the US Food and Drug Administration (US FDA) to market metronidazole tablets in strengths of 2...

The industrial licensing policy regime is one of the major factors contributing to the decline of the API industry.

The group now has more than 105 approvals and has so far filed nearly 275 ANDAs since the commencement of the filing process in FY 2003-04.

The product received approval in 17 months under the USFDA's new product clearance regime of GDUFA. The product is ready for immediate laun...

Drug firms such as Abbott Healthcare, Ipca Laboratories and Merck would be impacted by National Pharmaceutical Pricing Authority's (NPPA) m...

The S&P BSE Sensex cracks 700 points in trade on Tuesday after the Reserve Bank of India's policy review.

Indian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to remain in focus today.

Aurobindo Pharma has received US health regulator's approval to manufacture and market Metronidazole Tablets, used to treat various kinds o...

The drug is an anti-infective agent used to treat a variety of bacterial and protozoal infections.